Improving islet transplantation by gene delivery of hepatocyte growth factor (HGF) and its downstream target, protein kinase B (PKB)/Akt

Cell Biochemistry and Biophysics

Volumn 48, Issue 2-3, 2007, Pages 191-199

  Fiaschi Taesch, Nathalie ^a   Stewart, Andrew F ^a   Garcia Ocãa, Adolfo ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Diabetes; Gene therapy; Hepatocyte growth factor; Islet transplantation; Pancreatic beta cell; Protein kinase B

Indexed keywords

PROTEIN KINASE B; SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANIMAL; ARTICLE; CYTOLOGY; GENETIC TRANSFORMATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; METHODOLOGY; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION;

ANIMALS; DIABETES MELLITUS, TYPE 1; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; TRANSFORMATION, GENETIC;

MUS; RODENTIA; ANIMALIA;

EID: 34548309341     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-007-0024-7     Document Type: Article

References (57)

1. Becker, B. N., Odorico, J. S., Becker, Y. T., Groshek, M., Werwinski, C., Pirsch, J. D., & Sollinger, H. W. (2001). Simultaneous pancreas-kidney and pancreas transplantation. Journal of the American Society of Nephrology, 12, 2517-2527.
2. Gaglia, J. L., Shapiro, A. M., & Weir, G. C. (2005). Islet transplantation: Progress and challenge. Archives of Medical Research, 36, 273-280.
3. Shapiro, A. M., Lakey, J. R, Ryan, E. A., Korbutt, G. S., Toth, E., Warnock, G. L., Kneteman, N. M., & Rajotte, R. V. (2000). Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. New England Journal of Medicine, 343, 230-238.
4. Ryan, E. A., Lakey, J. R., Rajotte, R. V., Korbutt, G. S., Kin, T., Imes, S., Rabinovitch, A., Elliott, J. F., Bigam, D., Kneteman, N. M., Warnock, G. L., Larsen, I., & Shapiro, A. M. (2001). Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes, 50, 710-719.
5. Ryan, E. A., Lakey, J. R., Paty, B. W., Imes, S., Korbutt, G. S., Kneteman, N. M., Bigam, D., Rajotte, R. V., & Shapiro, A. M. (2002). Successful islet transplantation: Continued insulin reserve provides long-term glycemic control. Diabetes, 51, 2148-2157.
6. Ryan, E. A., Paty, B. W., Senior, P. A., Bigam, D., Alfadhli, E., Kneteman, N. M., Lakey, J. R., & Shapiro, A. M. (2005). Fiveyear follow-up after clinical islet transplantation. Diabetes, 54, 2060-2069.
7. Bretzel, R. G., Hering, B. J., & Federlin, K. F. (1995). Islet cell transplantation in diabetes mellitus - from bench to bedside. Experimental and Clinical Endocrinology and Diabetes, 103, 143-159.
8. Ricordi, C., Inverardi, L., Kenyon, N. S., Goss, J., Bertuzzi, F., & Alejandro, R. (2005). Requirements for success in clinical islet transplantation. Transplantation, 79, 1298-1300.
9. Rother, K. I., & Harlan, D. M. (2004). Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. Journal of Clinical Investigation, 114, 877-883.
10. Hering, B. J., Kandaswamy, R., Ansite, J. D., Eckman, P. M., Nakano, M., Sawada, T., Matsumoto, I., Ihm, S. H., Zhang, H. J., Parkey, J., Hunter, D. W., & Sutherland, D. E. (2005). Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA, 293, 830-835.
11. Matsumoto, S., Okitsu, T., Iwanaga, Y., Noguchi, H., Nagata, H., Yonekawa, Y., Yamada, Y., Fukuda, K., Tsukiyama, K., Suzuki, H., Kawasaki, Y., Shimodaira, M., Matsuoka, K., Shibata, T., Kasai, Y., Maekawa, T., Shapiro, J., & Tanaka, K. (2005). Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet, 365, 1642-1644.
12. Garcia-Ocana, A., Vasavada, R. C., Takane, K. K., Cebrian, A., Lopez-Talavera, J. C., & Stewart, A. F. (2001). Using beta-cell growth factors to enhance human pancreatic Islet transplantation. Journal of Clinical Endocrinology and Metabolism, 86, 984-988.
13. Hayek, A., & Beattie, G. M. (2002). Alternatives to unmodified human islets for transplantation. Current Diabetes Reports, 2, 371-376.
14. Stuart, K. A., Riordan, S. M., Lidder, S., Crostella, L., Williams, R., & Skouteris, G. G. (2000). Hepatocyte growth factor/scatter factor-induced intracellular signalling. International Journal of Experimental Pathology, 81, 17-30.
15. Furge, K. A., Zhang, Y. W., & Vande Woude, G. F. (2000). Met receptor tyrosine kinase: Enhanced signaling through adapter proteins. Oncogene, 19, 5582-5589.
16. Kataoka, H., Miyata, S., Uchinokura, S., & Itoh, H. (2003). Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metastasis Reviews, 22, 223-236.
17. Isaka, Y., Yamada, K., Takabatake, Y., Mizui, M., Miura-Tsujie, M., Ichimaru, N., Yazawa, K., Utsugi, R., Okuyama, A., Hori, M., Imai, E., & Takahara, S. (2005). Electroporation-mediated HGF gene transfection protected the kidney against graft injury. Gene Therapy, 12, 815-820.
18. Tambara, K., Premaratne, G. U., Sakaguchi, G., Kanemitsu, N., Lin, X., Nakajima, H., Sakakibara, Y., Kimura, Y., Yamamoto, M., Tabata, Y., Ikeda, T., & Komeda, M. (2005). Administration of control-released hepatocyte growth factor enhances the efficacy of skeletal myoblast transplantation in rat infarcted hearts by greatly increasing both quantity and quality of the graft. Circulation, 112, 129-134.
19. Yamaura, K., Ito, K., Tsukioka, K., Wada, Y., Makiuchi, A., Sakaguchi, M., Akashima, T., Fujimori, M., Sawa, Y., Morishita, R., Matsumoto, K., Nakamura, T., Suzuki, J., Amano, J., & Isobe, M. (2004). Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: Induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation, 110, 1650-1657.
20. Chen, Y., Kobayashi, N., Suzuki, S., Soto-Gutierrez, A., Rivas-Carrillo, J. D., Tanaka, K., Navarro-Alvarez, N., Fukazawa, T., Narushima, M., Miki, A., Okitsu, T., Amemiya, H., & Tanaka, N. (2005). Transplantation of human hepatocytes cultured with deleted variant of hepatocyte growth factor prolongs the survival of mice with acute liver failure. Transplantation, 79, 1378-1385.
21. Tashiro, H., Fudaba, Y., Itoh, H., Mizunuma, K., Ohdan, H., Itamoto, T., & Asahara, T. (2003). Hepatocyte growth factor prevents chronic allograft dysfunction in liver-transplanted rats. Transplantation, 76, 761-765.
22. Imado, T., Iwasaki, T., Kataoka, Y., Kuroiwa, T., Hara, H., Fujimoto, J., & Sano, H. (2004). Hepatocyte growth factor preserves graft-versus-leukemia effect and T-cell reconstitution after marrow transplantation. Blood, 104, 1542-1549.
23. Fiaschi-Taesch, N. M., Santos, S., Reddy, V., Van Why, S., Phillbrick, W. F., Ortega, A., Esbrit, P., Orloff, J. J., & Garcia-Ocaña, A. (2004). Prevention of acute ischemic renal failure by targeted delivery of growth factors to the proximal tubule in transgenic mice: The efficacy of HGF and PTHrP. Journal of the American Society of Nephrology, 15, 112-125.
24. Igawa, T., Matsumoto, K., Kanda, S., Saito, Y., & Nakamura, T. (1993). Hepatocyte growth factor may function as a renotropic factor for regeneration in rats with acute renal injury. American Journal of Physiology, 265, F61-F69.
25. Davalli, A. M., Scaglia, L., Zangen, D. H., Hollister, J., Bonner-Weir, S., & Weir, G. C. (1996). Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes, 45, 1161-1167.
26. Calvo, E. L., Boucher, C., Pelletier, G., & Morisset, J. (1996). Ontogeny of hepatocyte growth factor and c-met/hgf receptor in rat pancreas. Biochemical and Biophysical Research Communication, 229, 257-263.
27. Otonkoski, T., Cirulli, V., Beattie, M., Mally, M. I., Soto, G., Rubin, J. S., & Hayek, A. (1996). A role for hepatocyte growth factor/scatter factor in fetal mesenchyme-induced pancreatic beta-cell growth. Endocrinology, 137, 3131-3139.
28. Beattie, G. M., Rubin J. S., Mally, M. I., Otonkoski, T., & Hayek, A. (1996). Regulation of proliferation and differentiation of human fetal pancreatic islet cells by extracellular matrix, hepatocyte growth factor, and cell-cell contact. Diabetes, 45, 1223-1228.
29. Hayek, A., Beattie, G. M., Cirulli, V., Lopez, A. D., Ricordi, C., & Rubin, J. S. (1995). Growth factor/matrix-induced proliferation of human adult beta-cells. Diabetes, 44, 1458-1460.
30. Otonkoski, T., Beattie, G. M., Rubin, J. S., Lopez, A. D., Baird, A., & Hayek, A. (1994). Hepatocyte growth factor/scatter factor has insulinotropic activity in human fetal pancreatic cells. Diabetes, 43, 947-953.
31. Beattie, G. M., Montgomery, A. M., Lopez, A. D., Hao, E., Perez, B., Just, M. L., Lakey, J. R., Hart, M. E., & Hayek, A. (2002). A novel approach to increase human islet cell mass while preserving beta-cell function. Diabetes, 51, 3435-3439.
32. Garcia-Ocana, A., Takane, K. K., Syed, M. A., Philbrick, W. M., Vasavada, R. C., & Stewart, A. F. (2000). Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass, and induces mild hypoglycemia. Journal of Biological Chemistry, 275, 1226-1232.
33. Garcia-Ocana, A., Vasavada, R. C., Cebrian, A., Reddy, V., Takane, K. K., Lopez-Talavera, J. C., & Stewart, A. F. (2001). Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes, 50, 2752-2762.
34. Garcia-Ocana, A., Takane, K. K., Reddy, V. T., Lopez-Talavera, J. -C., Vasavada, R. C., & Stewart, A. F. (2003). Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. Journal of Biological Chemistry, 278, 343-351.
35. Gahr, S., Merger, M., Bollheimer, L. C., Hammerschmied, C. G., Scholmerich, J., & Hugl, S. R. (2002). Hepatocyte growth factor stimulates proliferation of pancreatic beta-cells particularly in the presence of subphysiological glucose concentrations. Journal of Molecular Endocrinology, 28, 99-110.
36. Mashima, H., Shibata, H., Mine, T., & Kojima, I. (1996). Formation of insulin-producing cells from pancreatic acinar AR42J cells by hepatocyte growth factor. Endocrinology, 137, 3969-3976.
37. Wang, R., Yashpal, N., Bacchus, F., & Li, J. (2004). Hepatocyte growth factor regulates proliferation and differentiation of epithelial monolayers derived from islets of postnatal rat pancreas. Journal of Endocrinology, 183, 163-171.
38. Kato, Y., Yu, D., & Schwartz, M. Z. (1998). Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection. Journal of Pediatric Surgery, 33, 13-15.
39. Nakano, M., Yasunami, Y., Maki, T., Kodama, S., Ikehara, Y., Nakamura, T., Tanaka, M., & Ikeda, S. (2000). Hepatocyte growth factor is essential for amelioration of hyperglycemia in streptozotocin-induced diabetic mice receiving a marginal mass of intrahepatic islet grafts. Transplantation, 69, 214-221.
40. Zioncheck, T. F., Richardson, L., Liu, J., Chang, L., King, K. L., Bennett, G. L., Fugedi, P., Chamow, S. M., Schwall, R. H., & Stack, R. J. (1995). Sulfated oligosaccharides promote hepatocyte growth factor association and govern its mitogenic activity. Journal of Biological Chemistry, 270, 16871-16878.
41. Takayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., Merlino, G. (1997). Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proceedings of the National Academy of Sciences of the United States of America, 94, 701-706.
42. Lopez-Talavera, J. C., Garcia-Ocana, A., Sipula, I., Takane, K. K., Cozar-Castellano, I., & Stewart, A. F. (2004). Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: Reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology, 145, 467-474.
43. Accili, D. (2001). A kinase in the life of the beta cell. Journal of Clinical Investigation, 108, 1575-1576.
44. Brazil, D. P., & Hemmings, B. A. (2001). Ten years of protein kinase B signaling: a hard Akt to follow. Trends in Biochemical Sciences, 26, 657-664.
45. Trumper, A., Trumper, K., & Horsch, D. (2002). Mechanisms of mitogenic and antiapoptotic signaling by glucose-dependent insulin-otropic polypeptide in beta (INS-1)-cells. Journal of Endocrinology, 174, 233-246.
46. Srinivasan, S., Bernal-Mizrachi, E., Ohsugi, M., & Permutt, M. A. (2002). Glucose promotes pancreatic islet beta cell survival through a PI 3-kinase/Akt signaling pathway. American Journal of Physiology Endocrinology and Metabolism, 283, E784-E793.
47. Brubaker, P. L., & Drucker, D. J. (2004). Minireview: Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology, 14, 2653-2659.
48. Dickson, L. M., Lingohr, M. K., McCuaig, J., Hugl, S. R., Snow, L., Kahn, B. B., Myers, M. G. Jr., & Rhodes, C. J. (2001). Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1). Journal of Biological Chemistry, 276, 21110-21120.
49. Holst, L. S., Mulder, H., Manganiello, V., Sundler, F., Ahren, B., Holm, C., & Degerman, E. (1998). Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I. Biochemical and Biophysical Research Communication, 250, 181-186.
50. Aikin, R., Maysinger, D., & Rosenberg, L. (2004). Cross-talk between phosphatidylinositiol 3-kinase/Akt and c-Jun NH2-terminal kinase mediates survival of isolated human islets. Endocrinology, 145, 4522-4531.
51. Tuttle, R. L., Gill, N. S., Pugh, W., Lee, J. P., Koeberlein, B., Furth, E. E., Polonsky, K. S., Naji, A., Birnbaum, M. J. (2001). Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBα. Nature Medicine, 7, 1133-1137.
52. Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt M. A. (2001). Islet beta cell expression of constitutively active Akt1/PKB alpha induces striking hypertrophy, hyperplasia, and hyperinsulinemia. Journal of Clinical Investigation, 108, 1631-1638.
53. Wrede, C. E., Dickson, L. M., Lingohr, M. K., Briaud, I., & Rhodes, C. J. (2002). Protein kinase B/Akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (INS-1). Journal of Biological Chemistry, 277, 49676-49684.
54. Mangi, A. A., Noiseux, N., Kong, D., He, H., Rezvani, M., Ingwall, J. S., & Dzau, V. J. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nature Medicine, 9, 1195-1201.
55. Contreras, J. L., Smyth, C. A., Bilbao, G., Young, C. J., Thompson, J. A., & Eckhoff, D. E. (2002). Simvastatin induces activation of the serine-threonine protein kinase Akt and increases survival of isolated human pancreatic islets. Transplantation, 74, 1063-1069.
56. Rao, P., Roccisana, J., Takane, K. K., Bottino, R., Zhao, A., Trucco, M., & Garcia-Ocana, A. (2005). Gene transfer of constitutively active Akt markedly improves human islet transplant outcomes in diabetic severe combined immunodeficient mice. Diabetes, 54, 1664-1675.
57. Plesner, A., Liston, P., Tan, R., Korneluk, R. G., & Verchere, C. B. (2005). The x-linked inhibitor of apoptosis protein enhances survival of murine islet allografts. Diabetes, 54, 2533-2540.